market access

Are we measuring what matters most on uptake to medicines in England?

https://pharmaphorum.com/market-access-2/measuring-uptake-medicines-england/

Getting better at measuring international uptake of medicines?

https://pharmaphorum.com/market-access-2/getting-better-at-measuring-international-uptake-of-medicines/

Patient and market insights from leading KOLs and life science leaders

https://pharmaphorum.com/partner-content/patient-and-market-insights-from-leading-kols-and-life-science-leaders/

Sustained healthcare systems need sustainable pharma business models

https://pharmaphorum.com/sales-marketing/healthcare-systems-pharma-business-models/

Scotland backs Cabometyx combo for kidney cancer, amid stalled NICE review

https://pharmaphorum.com/news/scotland-backs-cabometyx-combo-for-kidney-cancer-amid-stalled-nice-review/

Moderna unveils $500m plan for African vaccine facility

https://pharmaphorum.com/news/moderna-unveils-500m-plan-for-african-vaccine-facility/

Joy as sickle cell patients get access to Novartis’ Adakveo after NICE ruling

https://pharmaphorum.com/news/joy-as-sickle-cell-patients-get-access-to-novartis-adakveo-after-nice-ruling/

16th Park Annual by Sahlgrenska Science Park

https://pharmaphorum.com/events/16th-park-annual-by-sahlgrenska-science-park/

https://pharmaphorum.com/news/nice-backs-cosentyx-use-in-thousands-of-children-with-psoriasis/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search